- Report
- March 2025
- 373 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- December 2024
- 150 Pages
Global
From €4604EUR$4,850USD£3,884GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1424EUR$1,500USD£1,201GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1187EUR$1,250USD£1,001GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1899EUR$2,000USD£1,602GBP
- Report
- May 2024
- 134 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- June 2024
- 200 Pages
Global
From €7547EUR$7,950USD£6,366GBP
- Report
- June 2024
- 200 Pages
Global
From €7547EUR$7,950USD£6,366GBP
- Report
- June 2024
- 200 Pages
Global
From €7547EUR$7,950USD£6,366GBP
- Report
- September 2023
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- January 2022
- 60 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- January 2022
- 60 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- January 2022
- 60 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- September 2024
- 85 Pages
India
From €3323EUR$3,500USD£2,803GBP
- Report
- November 2023
- 75 Pages
United States
From €3323EUR$3,500USD£2,803GBP
- Report
- October 2023
- 190 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- September 2022
- 104 Pages
Global
From €1899EUR$2,000USD£1,602GBP
- Report
- May 2022
- 37 Pages
Global
From €1899EUR$2,000USD£1,602GBP

Aspergillosis is a type of fungal infection caused by the Aspergillus fungus. It can affect the lungs, sinuses, and other organs. Treatment for aspergillosis typically involves antifungal medications. The Aspergillosis Drug market is a subset of the larger Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Aspergillosis drugs are used to treat a variety of forms of the infection, including allergic bronchopulmonary aspergillosis, chronic pulmonary aspergillosis, and invasive aspergillosis. These drugs are typically administered orally or intravenously.
Some companies in the Aspergillosis Drug market include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more